FDA approves nasal spray to treat depression

The FDA approved Johnson & Johnson's Spravato nasal spray, the first-ever stand-alone therapy for treatment-resistant depression.

Other contents

'It felt like you were in a war zone': Witness describes NYC shooting

Shooter 'sprayed' gunfire in building lobby: hear the NYC mass shooting news conference

Mass shooting in New York City leaves multiple dead, including the suspected gunman

Witness recounts Midtown Manhattan shooting: 'All of us were shocked'

Breaking News: NYC police officer killed by gunman, others wounded, sources say

What to know about Trump trade agreement with European Union

Former homicide detective decries New York shooting: 'This is just senseless violence'

4 people, including NYPD officer, killed in Midtown Manhattan shooting, official says

UPDATE: 4 civilians, 1 NYPD officer dead in Manhattan shooting

Three dead, including off-duty NYPD police officer, in Midtown Manhattan shooting